5,755 results on '"Acute Coronary Syndromes"'
Search Results
52. Electrocardiographic criteria for anterior STEMI – Does the cut-off point affect treatment delay?
53. Impact of renal function on outcomes of patients with cardiac troponin elevation and non-obstructive coronary arteries
54. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study
55. Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry
56. Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome
57. Can OCT change the therapeutic strategy in ACS due to plaque erosion?
58. High sensitivity troponin, analytical advantages, clinical benefits and clinical challenges – An update
59. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction
60. Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores
61. Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial
62. Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry
63. STEMI: A transitional fossil in MI classification?
64. Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes
65. Causes of mortality in a department of cardiology over a 15-year period
66. Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
67. Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The “macro-hub” experience
68. Therapeutic management and outcome of nonagenarians versus octogenarians admitted to an intensive care unit for acute coronary syndromes
69. Machine Learning Improves the Identification of Individuals With Higher Morbidity and Avoidable Health Costs After Acute Coronary Syndromes
70. Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
71. Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: Evidence from an Italian real-world investigation
72. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece
73. Outcomes of different revascularization strategies among patients presenting with acute coronary syndromes without ST elevation
74. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
75. Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT
76. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability
77. Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis
78. Cardiac biomarker measurement by point of care testing – Development, rationale, current state and future developments
79. Long-Term Outcomes of Complete Revascularization With Percutaneous Coronary Intervention in Acute Coronary Syndromes
80. What's in a prick? Vaccines and the cardiovascular system
81. Impact of Diabetes Mellitus and Frailty on Long-Term Outcomes in Elderly Patients with Acute Coronary Syndromes
82. Racial and insurance disparities among patients presenting with chest pain in the US: 2009–2015
83. Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24
84. Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction
85. Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial
86. Prognosis of acute coronary syndromes after radiotherapy for breast cancer
87. Diastolic dysfunction grade in acute coronary syndromes: Application of 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations
88. Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review
89. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay
90. Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort
91. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction
92. Impacto del bloqueo del sistema renina-angiotensina en el pronóstico del síndrome coronario agudo en función de la fracción de eyección
93. 10 - Cardiothoracic surgery
94. 6 - Vascular surgery
95. 28 - Cardiovascular system
96. Chapter 7 - Acute Coronary Syndromes
97. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
98. Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors
99. Clinicopathological complexity in the application of the universal definition of myocardial infarction
100. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.